CYP2W1 | bioCADDIE Data Discovery Index
Mountain View
biomedical and healthCAre Data Discovery Index Ecosystem
help Advanced Search
Displaying 7 of 7 results for "CYP2W1"
i
  1. MHC complexed to 11mer peptide PDB

    ID: PDB:5F1N

    Description: MHC class I antigen, Beta-2-microglobulin, Peptide from Cytochrome P450 family 1 ...

  2. CP2W1_MOUSE UniProt:Swiss-Prot

    ID: E9Q816

    Description: Cytochrome P450 2W1 Iron (heme axial ligand) N-linked (GlcNAc...)

  3. CP2W1_HUMAN UniProt:Swiss-Prot

    ID: Q8TAV3

    Description: Cytochrome P450 2W1 Iron (heme axial ligand) N-linked (GlcNAc...) Associated with increased colorectal cancer r...

  4. The expression profile of cytochromes P450 (CYPs) and aldo-keto reductases (AKRs) in post-treatment breast carcinomas BioProject

    ID: PRJNA242772

    Keywords: Transcriptome or Gene expression

    Access Type: download

  5. The expression profile of cytochromes P450 (CYPs) and aldo-keto reductases (AKRs) in post-treatment breast carcinomas ArrayExpress

    ID: E-GEOD-56259

    Description: higher intratumoral levels of AKR1C1, AKR1C2, and CYP2W1 were found in responders to NACT compared with non-responders. Patients with high AKR1C2 and CYP3A4 levels had significantly longer disease-free survival than patients with low levels. Transcript levels of twenty-four selected human metabolic genes (CYPs and AKRs) were determined by qPCR in post-treatment tumor and non-neoplastic tissue samples from 68 breast carcinoma patients treated by anthracycline and/or taxane based neoadjuvant chemotherapy. EIF2B1, MRPL19, IPO8, and UBB were used as reference genes for data normalization....

  6. The expression profile of cytochromes P450 (CYPs) and aldo-keto reductases (AKRs) in post-treatment breast carcinomas OmicsDI

    ID: E-GEOD-56259

    Date Released: 09-07-2014

    Description: higher intratumoral levels of AKR1C1, AKR1C2, and CYP2W1 were found in responders to NACT compared with non-responders. Patients with high AKR1C2 and CYP3A4 levels had significantly longer disease-free survival than patients with low levels. Transcript levels of twenty-four selected human metabolic genes (CYPs and AKRs) were determined by qPCR in post-treatment tumor and non-neoplastic tissue samples from 68 breast carcinoma patients treated by anthracycline and/or taxane based neoadjuvant chemotherapy. EIF2B1, MRPL19, IPO8, and UBB were used as reference genes for data normalization....

  7. Marked methylation changes of intestinal genes in the neonatal period of preterm neonates BioProject

    ID: PRJNA232784

    Keywords: Epigenomics

    Access Type: download

    dataset.description: preterm-NEC vs. 4d-preterm) in pigs (each group n=2-3). Differentially methylated gene regions (DMRs) between the groups were identified, subjected to KEGG (Kyoto Encyclopedia of Genes and Genomes) pathway analysis and selected genes were chosen for further validation of gene expression levels by RT-PCR (n= 6 for each group). Consistent with the need to increase expression of many intestinal genes in the perinatal period, methylation levels of most genes decreased during the prenatal and neonatal periods. We identified four intestinal genes (CYP2W1, GPR146, TOP1MT, CEND1), r...

Displaying 7 of 7 results for "CYP2W1"